Resistant starches for the management of metabolic diseases

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 18, Issue 6, 2015, Pages 559-565

  Bindels, Laure B ^a   Walter, Jens ^b,c   Ramer Tait, Amanda E ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b Food and Nutritional Science ^*  (India)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bile Acids; Gut Microbiota; Insulin Sensitivity; Macrophages; Resistant Starches

Indexed keywords

GLUCOSE; INSULIN; RESISTANT STARCH; SHORT CHAIN FATTY ACID; STARCH; UNCLASSIFIED DRUG;

BODY COMPOSITION; BODY WEIGHT; CARBOHYDRATE DIET; CLINICAL TRIAL (TOPIC); DYSLIPIDEMIA; GLUCOSE HOMEOSTASIS; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE FLORA; MEDIATOR; METABOLIC DISORDER; NONHUMAN; REVIEW; ADIPOSE TISSUE; ANIMAL; BLOOD; DIET THERAPY; DIETARY FIBER; DIGESTION; DISEASE MANAGEMENT; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY;

ADIPOSE TISSUE; ANIMALS; DIETARY FIBER; DIGESTION; DISEASE MANAGEMENT; GASTROINTESTINAL TRACT; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLIC DISEASES; STARCH;

EID: 84944051979     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000223     Document Type: Review

References (40)

1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:766-781
2. Cani PD, Van Hul M. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol 2015; 32:21-27
3. Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014; 2014: article 943162
4. Hamaker BR, Tuncil YE. A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota. J Mol Biol 2014; 426:3838-3850
5. Keenan MJ, Zhou J, Hegsted M, et al. Role of resistant starch in improving gut health, adiposity, and insulin resistance. Adv Nutr 2015; 6:198-205
6. Bodinham CL, Smith L, Thomas EL, et al. Efficacy of increased resistant starch consumption in human type 2 diabetes. Endocr Connect 2014; 3:75-84
7. Maki KC, Phillips AK. Dietary substitutions for refined carbohydrate that show promise for reducing risk of type 2 diabetes in men and women. J Nutr 2015; 145:159S-163S.
8. Englyst H, Wiggins HS, Cummings JH. Determination of the nonstarch polysaccharides in plant foods by gas-liquid chromatography of constituent sugars as alditol acetates. Analyst 1982; 107:307-318
9. Johnston KL, Thomas EL, Bell JD, et al. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med 2010; 27:391-397
10. Zhou Z, Wang F, Ren X, et al. Resistant starch manipulated hyperglycemia/hyperlipidemia and related genes expression in diabetic rats. Int J Biol Macromol 2015; 75:316-321
11. Harazaki T, Inoue S, Imai C, et al. Resistant starch improves insulin resistance and reduces adipose tissue weight and CD11c expression in rat OLETF adipose tissue. Nutrition 2014; 30:590-595
12. Dodevska MS, Sobajic SS, Djordjevic PB, et al. Effects of total fibre or resistant starch-rich diets within lifestyle intervention in obese prediabetic adults. Eur J Nutr 2015. [Epub ahead of print]
13. Nichenametla SN, Weidauer LA, Wey HE, et al. Resistant starch type 4-enriched diet lowered blood cholesterols and improved body composition in a double blind controlled cross-over intervention. Mol Nutr Food Res 2014; 58:1365-1369
14. Higgins JA. Resistant starch and energy balance: impact on weight loss and maintenance. Crit Rev Food Sci Nutr 2014; 54:1158-1166
15. Khan MT, Nieuwdorp M, Backhed F. Microbial modulation of insulin sensitivity. Cell Metab 2014; 20:753-760
16. Geurts L, Neyrinck AM, Delzenne NM, et al. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 2014; 5:3-17
17. Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol 2014; 49:785-798
18. Martinez I, Kim J, Duffy PR, et al. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 2010; 5:e15046
19. Lange K, Hugenholtz F, Jonathan MC, et al. Comparison of the effects of five dietary fibers on mucosal transcriptional profiles, and luminal microbiota composition and SCFA concentrations in murine colon. Mol Nutr Food Res 2015; 59:1590-1602
20. Tachon S, Zhou J, Keenan M, et al. The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses. FEMS Microbiol Ecol 2013; 83:299-309
21. Haenen D, Zhang J, Souza da SC, et al. A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J Nutr 2013; 143:274-283
22. Salonen A, Lahti L, Salojarvi J, et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J 2014; 8:2218-2230
23. Umu OC, Frank JA, Fangel JU, et al. Resistant starch diet induces change in the swine microbiome and a predominance of beneficial bacterial populations. Microbiome 2015; 3:16
24. Bindels LB, Dewulf EM, Delzenne NM. GPR43/FFA2: physiopathological relevance and therapeutic prospects. Trends Pharmacol Sci 2013; 34:226-232
25. Puertollano E, Kolida S, Yaqoob P. Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. CurrOpin Clin NutrMetab Care 2014; 17:139-144
26. Jakobsdottir G, Nyman M, Fak F. Designing future prebiotic fiber to target metabolic syndrome. Nutrition 2014; 30:497-502
27. Li T, Chiang JY. Bile acids as metabolic regulators. Curr Opin Gastroenterol 2015; 31:159-165
28. Perino A, Pols TW, Nomura M, et al. TGR5 reduces macrophage migration through mTOR-induced C/EBPbeta differential translation. J Clin Invest 2014; 124:5424-5436
29. Zhou J, Martin RJ, Raggio AM, et al. The importance of GLP-1 and PYY in resistant starchs effect on body fat in mice. Mol Nutr Food Res 2015; 59:1000-1003
30. Bodinham CL, Al-Mana NM, Smith L, Robertson MD. Endogenous plasma glucagon-like peptide-1 following acute dietary fibre consumption. Br J Nutr 2013; 110:1429-1433
31. Ebihara K, Shiraishi R, Okuma K. Hydroxypropyl-modified potato starch increases fecal bile acid excretion in rats. J Nutr 1998; 128:848-854
32. Patsouris D, Li PP, Thapar D, et al. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 2008; 8:301-309
33. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity 2014; 41:36-48
34. Walker AW, Ince J, Duncan SH, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011; 5:220-230
35. Miquel S, Leclerc M, Martin R, et al. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. MBio 2015; 6:e00300-e315
36. Walter J, Martinez I, Rose DJ. Holobiont nutrition: considering the role of the gastrointestinal microbiota in the health benefits of whole grains. Gut Microbes 2013; 4:340-346
37. Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015; 12:303-310
38. Martinez I, Stegen JC, Maldonado-Gomez MX, et al. The gut microbiota of rural papua new guineans: composition, diversity patterns, and ecological processes. Cell Rep 2015; 11:527-538
39. Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 2012; 6:1535-1543
40. Scott KP, Antoine JM, Midtvedt T, van HS. Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis 2015; 26: article 25877.